PET/MRI imaging in neuroendocrine neoplasm

Mayur K. Virarkar, Matthew Montanarella, Malak Itani, Luis Calimano-Ramirez, Dheeraj Gopireddy, Priya Bhosale

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Molecular imaging plays a vital role in the management of neuroendocrine neoplasms (NENs). Somatostatin receptor (SSTR) PET is critical for evaluating NENs, ascertaining peptide receptor radionuclide therapy (PRRT) eligibility, and treatment response. SSTR-PET/MRI can provide a one-stop-shop multiparametric evaluation of NENs. The acquisition of complementary imaging information in PET/MRI has distinct advantages over PET/CT and MR imaging acquisitions. The purpose of this manuscript is to provide a comprehensive overview of PET/MRI and a current review of recent PET/MRI advances in the diagnosis, staging, treatment, and surveillance of NENs.

Original languageEnglish
Pages (from-to)3585-3600
Number of pages16
JournalAbdominal Radiology
Issue number12
StatePublished - Dec 2023


  • Neuroendocrine neoplasm
  • PET/CT
  • PPRT
  • SSTR


Dive into the research topics of 'PET/MRI imaging in neuroendocrine neoplasm'. Together they form a unique fingerprint.

Cite this